MedStartr Venture Fund 3

2022 signals the launch of our 3rd fund

We have begun the process of forming our next fund, planned to be $50-100M to scale the model and have already received positive indications from individuals, family offices as well as strategic corporate and institutional investors.  We expect first closings for MVF III in Q2 2022. 

Programs will be co-designed by the Strategic Investor and the MedStartr teams to maximize engagement and find the best new ideas available for investment and acceleration.

 

All of our portfolio will placed into the MedStartr accelerator program.  This has been great and all our teams are not only still in business, on average in the last 6 months they grew by over 120% and have averaged over 78% growth per year.

Fund Thesis:

Scaling MedStartr Crowd-Validation and Acceleration Model developed in our first two funds and applying capital to opportunities sourced from our market position and previous investments. Includes Acceleration services in pre-Series A investments to improve success rates.

The MedStartr Model

Our People

Our global community of over 130,000 Patients, Doctors, Nurses, Hospital Leaders, Investors and Industry Executives that drive innovation.

Our Process

Structured programs with our community source and select the best startups in contests that feed our predictive algorithm for startup success.

Our Performance

Early-Stage Startups selected by the MedStartr Algorithm have doubled in value every 10-13 months on average 

our people.png
our performace.png
our process.png
arrow&v
Are you an accredited investor?

Want More Info About Fund